Tag Archives: Aveo Oncology

March, 2015

  • 6 March

    Aveo Presents Promising Results for its Colorectal Cancer Drug

    Today, Aveo Oncology announced that its drug, tivozanib, appears to have stopped the growth of advanced colorectal cancer better than Avastin (bevacizumab). The company presented final results from the BATON CRC study, a Phase II clinical trial of modified FOLFOX6 combined with tivozanib or bevacizumab in metastatic colorectal cancer (CRC) …